RISK OF MYELODYSPLASTIC SYNDROMES IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE

被引：0
|
作者：
Pleyer, C. [1 ]
Sidana, S. [1 ]
Erik, O. [2 ]
Radivoyevitch, T. [3 ]
Advani, A. S. [4 ]
Gerds, A. T. [4 ]
Carraway, H. [4 ]
Kalaycio, M. [4 ]
Maciejewski, J. P. [4 ]
Sekeres, M. A. [4 ]
Mukherjee, S. [4 ]
机构：
[1] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30080-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
79
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [21] PIGU modulates radioactive iodine uptake in differentiated thyroid cancers
    Amit, Moran
    Na'ara, Shorook
    Charas, Tomer
    Gil, Ziv
    CANCER RESEARCH, 2016, 76
  • [22] Risk of developing acute myeloid leukemia (AML) in well-differentiated thyroid cancer (WDTC) patients treated with radioactive iodine (RAI): a population-based study
    Molenaar, R. J.
    Radivoyevitch, T.
    Carraway, H. E.
    Maciejewski, J. P.
    Sekeres, M. A.
    Mukherjee, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Rare Metastases of Well-Differentiated Thyroid Cancers: A Systematic Review
    Madani, Amin
    Jozaghi, Yelda
    Tabah, Roger
    How, Jacques
    Mitmaker, Elliot
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) : 460 - 466
  • [24] Recent Advances in Our Understanding of Well-Differentiated Thyroid Cancers
    Krishnamurthy A.
    Ramshankar V.
    Indian Journal of Surgical Oncology, 2017, 8 (3) : 255 - 257
  • [25] Chapter 5: Surgery for Neck in Well-differentiated Thyroid Cancers
    Vaidya, Abhishek
    Sarin, Deepak
    JOURNAL OF HEAD & NECK PHYSICIANS AND SURGEONS, 2024, 12 (SUPPL 1): : S22 - S28
  • [26] Rare Metastases of Well-Differentiated Thyroid Cancers: A Systematic Review
    Amin Madani
    Yelda Jozaghi
    Roger Tabah
    Jacques How
    Elliot Mitmaker
    Annals of Surgical Oncology, 2015, 22 : 460 - 466
  • [27] Should tall cell thyroid cancers be evaluated differently from well-differentiated thyroid cancers?
    Dalci, Kubilay
    Topal, Ugur
    Unal, Ayse Gizem
    Saritas, Ahmet Gokhan
    Guney, Isa Burak
    Uguz, Aysun Hatice
    Sakman, Gurhan
    ANNALI ITALIANI DI CHIRURGIA, 2021, 92 (02) : 123 - 130
  • [28] Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation
    Shen, Feng-Chih
    Hsieh, Ching-Jung
    Huang, I-Chin
    Chang, Yen-Hsiang
    Wang, Pei-Wen
    THYROID, 2017, 27 (04) : 531 - 536
  • [29] Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy
    Lang, Brian Hung-Hin
    Wong, Irene Oi Ling
    Wong, Kai Pun
    Cowling, Benjamin J.
    Wan, Koon-Yat
    SURGERY, 2012, 151 (06) : 844 - 850
  • [30] Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
    Momesso, Denise P.
    Vaisman, Fernanda
    Yang, Samantha P.
    Bulzico, Daniel A.
    Corbo, Rossana
    Vaisman, Mario
    Tuttle, R. Michael
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (07): : 2692 - 2700
12345